Your browser is no longer supported. Please, upgrade your browser.
Settings
PGEN [NASD]
Precigen, Inc.
Index- P/E- EPS (ttm)-0.56 Insider Own13.50% Shs Outstand193.50M Perf Week9.90%
Market Cap1.44B Forward P/E- EPS next Y-0.60 Insider Trans-12.41% Shs Float178.03M Perf Month7.64%
Income-95.70M PEG- EPS next Q-0.12 Inst Own70.90% Short Float12.46% Perf Quarter-18.19%
Sales97.90M P/S14.74 EPS this Y43.30% Inst Trans17.63% Short Ratio18.66 Perf Half Y-12.00%
Book/sh0.90 P/B8.14 EPS next Y-33.30% ROA-37.20% Target Price12.33 Perf Year98.64%
Cash/sh0.54 P/C13.65 EPS next 5Y2.40% ROE-150.60% 52W Range3.36 - 11.10 Perf YTD-28.14%
Dividend- P/FCF- EPS past 5Y4.00% ROI-36.20% 52W High-33.96% Beta2.32
Dividend %- Quick Ratio5.30 Sales past 5Y-9.90% Gross Margin43.90% 52W Low118.15% ATR0.50
Employees563 Current Ratio5.70 Sales Q/Q-17.80% Oper. Margin-80.40% RSI (14)57.54 Volatility8.94% 6.57%
OptionableYes Debt/Eq1.00 EPS Q/Q13.20% Profit Margin- Rel Volume9.74 Prev Close6.99
ShortableYes LT Debt/Eq1.00 EarningsMay 10 AMC Payout- Avg Volume1.19M Price7.33
Recom2.00 SMA208.67% SMA503.45% SMA2004.44% Volume11,575,493 Change4.86%
Feb-25-21Initiated Stifel Buy $13
Feb-22-21Initiated Wells Fargo Overweight $14
Feb-18-21Initiated B. Riley Securities Buy $10
May-08-20Initiated H.C. Wainwright Buy $5
Jun-10-21 05:05PM  
04:05PM  
May-10-21 04:30PM  
Apr-28-21 12:33PM  
Mar-30-21 04:05PM  
Mar-25-21 05:46AM  
Mar-23-21 08:05AM  
Mar-18-21 08:30AM  
Mar-01-21 04:05PM  
02:30PM  
Feb-22-21 04:05PM  
Feb-04-21 04:05PM  
Jan-26-21 04:05PM  
Jan-22-21 08:05AM  
Jan-21-21 04:01PM  
Jan-13-21 04:05PM  
Jan-12-21 07:15AM  
Jan-06-21 08:05AM  
Jan-05-21 08:05AM  
Dec-25-20 03:36AM  
Dec-15-20 07:37PM  
Dec-11-20 07:05PM  
Dec-08-20 04:05PM  
07:05AM  
Dec-07-20 10:05AM  
Dec-04-20 11:30AM  
11:00AM  
09:37AM  
09:05AM  
08:00AM  
Dec-03-20 11:58PM  
05:29PM  
04:54PM  
01:20PM  
01:00PM  
10:40AM  
09:30AM  
04:25AM  
01:00AM  
Dec-02-20 02:30PM  
02:12PM  
11:00AM  
11:00AM  
09:37AM  
Dec-01-20 11:59PM  
02:42PM  
11:00AM  
09:18AM  
Nov-30-20 08:00PM  
04:31PM  
01:00PM  
11:00AM  
09:20AM  
Nov-29-20 03:21PM  
01:00PM  
Nov-28-20 01:16PM  
09:39AM  
09:00AM  
Nov-27-20 05:00PM  
03:57PM  
10:28AM  
10:11AM  
Nov-26-20 01:30PM  
Nov-25-20 04:38PM  
12:52PM  
12:45PM  
12:40PM  
11:00AM  
Nov-24-20 06:00PM  
01:46PM  
01:00PM  
11:00AM  
10:19AM  
09:16AM  
Nov-23-20 11:15PM  
05:04PM  
03:12PM  
12:00PM  
11:00AM  
Nov-22-20 12:24AM  
Nov-20-20 05:42PM  
Nov-19-20 03:55PM  
10:58AM  
Nov-18-20 10:00PM  
05:00PM  
03:52PM  
12:19PM  
12:15PM  
Nov-17-20 05:06PM  
04:04PM  
12:30PM  
11:00AM  
09:39AM  
Nov-16-20 09:51PM  
04:50PM  
11:30AM  
08:05AM  
Nov-14-20 04:15PM  
Nov-13-20 07:04PM  
04:10PM  
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; proprietary methane bioconversion platform that turns natural gas into energy and chemical products; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorporates advanced DNA construction technologies and computational models to design and assemble genetic components into complex gene expression programs; mbIL15, a gene that enhances functional characteristics of immune cells; Sleeping Beauty, a non-viral transposon/transposase system; AttSite recombinases, which breaks and rejoins DNA at specific sequences; AdenoVerse technology platform, a library of engineered adenovector serotypes; and L. lactis is a food-grade bacterium. Additionally, it provides RheoSwitch inducible gene switch that provides quantitative dose-proportionate regulation of the amount and timing of target protein expression; kill switches to selectively eliminate cell therapies in vivo; UltraCAR-T platform for the treatment of cancer; AdenoVerse Immunotherapy, a library of proprietary adenovectors for the gene delivery; and ActoBiotics platform, genetically modified bacteria that deliver proteins and peptides at mucosal sites. Precigen, Inc. has collaboration and license agreements with ZIOPHARM Oncology, Inc.; Ares Trading S.A.; Oragenics, Inc.; Intrexon T1D Partners, LLC; Intrexon Energy Partners, LLC; Intrexon Energy Partners II, LLC; Fibrocell Science, Inc.; OvaXon, LLC; S & I Ophthalmic, LLC; Harvest start-up entities; and Surterra Holdings, Inc. The company was formerly known as Intrexon Corporation and changed its name to Precigen, Inc. in January 2020. Precigen, Inc. was founded in 1998 and is based in Germantown, Maryland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Ares Trading S.A.10% OwnerJun 10Sale7.0991,991652,55723,852,436Jun 11 06:00 PM
Ares Trading S.A.10% OwnerJun 09Sale7.22155,2271,120,61523,944,427Jun 11 06:00 PM
Ares Trading S.A.10% OwnerJun 08Sale7.15226,2561,618,13824,099,654Jun 09 06:00 PM
Ares Trading S.A.10% OwnerJun 07Sale6.97203,2331,416,71724,325,910Jun 09 06:00 PM
Ares Trading S.A.10% OwnerJun 04Sale6.6676,685510,40824,529,143Jun 07 06:06 PM
Ares Trading S.A.10% OwnerJun 03Sale6.5983,992553,80124,605,828Jun 07 06:06 PM
Ares Trading S.A.10% OwnerJun 02Sale6.61121,400802,66024,689,820Jun 03 06:00 PM
Ares Trading S.A.10% OwnerJun 01Sale6.63106,600706,61924,811,220Jun 03 06:00 PM
Ares Trading S.A.10% OwnerMay 28Sale6.7972,811494,45224,917,820Jun 01 06:01 PM
Ares Trading S.A.10% OwnerMay 27Sale6.80166,1471,129,16824,990,631May 28 06:00 PM
Ares Trading S.A.10% OwnerMay 26Sale6.60169,0001,115,82225,156,778May 28 06:00 PM
Ares Trading S.A.DirectorMay 25Sale6.4686,288557,28225,325,778May 26 06:00 PM
Ares Trading S.A.DirectorMay 24Sale6.5762,469410,55325,412,066May 26 06:00 PM
Ares Trading S.A.10% OwnerMay 21Sale6.86131,409901,00625,474,535May 24 06:00 PM
Ares Trading S.A.10% OwnerMay 20Sale6.61149,648988,73925,605,944May 24 06:00 PM
Lehr Donald P.Chief Legal OfficerMay 19Sale6.638,90759,049291,847May 20 06:15 PM
Ares Trading S.A.10% OwnerMay 19Sale6.50121,500789,62825,755,592May 20 06:00 PM
Ares Trading S.A.10% OwnerMay 18Sale6.85134,043918,57025,877,092May 20 06:00 PM
Ares Trading S.A.10% OwnerMay 17Sale6.7579,355535,98726,011,135May 18 06:00 PM
Ares Trading S.A.10% OwnerMay 14Sale6.71185,3601,244,30326,090,490May 18 06:00 PM
Sabzevari HelenPresident and CEOMay 13Sale6.4047,433303,571705,057May 14 06:43 PM
Ares Trading S.A.10% OwnerMay 13Sale6.52122,389798,18426,275,850May 14 06:02 PM
Ares Trading S.A.10% OwnerMay 12Sale7.00150,0001,050,51026,398,239May 14 06:02 PM
Ares Trading S.A.10% OwnerMay 11Sale6.40151,164966,93626,548,239May 12 06:00 PM
Ares Trading S.A.10% OwnerMay 10Sale6.34114,603726,74326,699,403May 12 06:00 PM
Ares Trading S.A.10% OwnerMay 07Sale6.55150,000982,48526,814,006May 10 06:01 PM
Ares Trading S.A.10% OwnerMay 06Sale6.54100,000653,85026,964,006May 10 06:01 PM
Ares Trading S.A.10% OwnerMay 05Sale6.8657,261392,63927,064,006May 06 07:10 PM
Ares Trading S.A.10% OwnerMay 04Sale7.0894,950672,23727,121,267May 06 07:10 PM
Ares Trading S.A.10% OwnerMay 03Sale7.4774,172553,99127,216,217May 04 06:01 PM
Ares Trading S.A.10% OwnerApr 30Sale7.90108,130853,74027,290,389May 04 06:01 PM
ALVAREZ CESAR LDirectorMar 03Option Exercise5.692,96816,888187,101Mar 05 05:05 PM
Frank StevenDirectorMar 03Option Exercise5.692,96816,888268,531Mar 05 05:02 PM
MITCHELL DEAN JDirectorMar 03Option Exercise5.692,96816,888108,409Mar 05 04:58 PM
Sabzevari HelenPresident and CEOJan 06Sale8.92260,0452,318,535655,214Jan 07 04:26 PM
Sterling Rick L.Chief Financial OfficerJan 05Sale10.566,09664,404340,020Jan 06 04:40 PM
Sabzevari HelenPresident and CEOJan 05Sale10.569,04095,507415,259Jan 06 04:37 PM
Perez Jeffrey ThomasSVP, IP AffairsJan 05Sale10.569,04995,602279,821Jan 06 04:34 PM
Lehr Donald P.Chief Legal OfficerJan 05Sale10.569,677102,237274,652Jan 06 04:31 PM
Lehr Donald P.Chief Legal OfficerJan 04Sale10.165,27153,553265,389Jan 05 05:35 PM
Sabzevari HelenPresident and CEOJan 04Sale10.165,27953,635406,632Jan 05 05:33 PM
Perez Jeffrey ThomasSVP, IP AffairsJan 04Sale10.164,95150,302269,930Jan 05 05:34 PM
Sterling Rick L.Chief Financial OfficerJan 04Sale10.163,48735,428327,176Jan 05 05:32 PM
Sterling Rick L.Chief Financial OfficerDec 16Sale7.209,41667,795320,897Dec 17 05:18 PM
Perez Jeffrey ThomasSVP, IP AffairsDec 16Sale7.209,38267,550258,847Dec 17 05:17 PM
Lehr Donald P.Chief Legal OfficerDec 16Sale7.2012,19087,768260,894Dec 17 05:15 PM
Ares Trading S.A.10% OwnerOct 07Buy3.706,758,40024,999,99727,398,519Oct 09 08:09 AM
Sterling Rick L.Chief Financial OfficerSep 16Sale5.227,66039,985305,313Sep 17 06:39 PM
Perez Jeffrey ThomasSVP, IP AffairsSep 16Sale5.227,66039,985243,229Sep 17 06:35 PM
Lehr Donald P.Chief Legal OfficerSep 16Sale5.228,47444,234248,084Sep 17 06:29 PM
KIRK RANDAL JExecutive ChairmanAug 12Buy4.26400,8661,707,68913,495,622Aug 13 04:24 PM
KIRK RANDAL JExecutive ChairmanAug 11Buy4.50808,5183,638,33113,216,701Aug 13 04:24 PM
Sabzevari HelenPresident and CEOJul 20Sale4.5812,22055,968402,145Jul 21 06:40 PM
Frank StevenDirectorJun 30Option Exercise3.172,9689,409265,563Jul 06 04:22 PM
ALVAREZ CESAR LDirectorJun 23Option Exercise3.172,9689,409184,133Jun 25 04:22 PM
MITCHELL DEAN JDirectorJun 19Option Exercise3.172,9689,409105,441Jun 23 04:57 PM
Lehr Donald P.Chief Legal OfficerJun 16Sale4.508,42837,926231,558Jun 17 04:35 PM
Perez Jeffrey ThomasSVP, IP AffairsJun 16Sale4.507,61934,286225,889Jun 17 04:32 PM
Sterling Rick L.Chief Financial OfficerJun 16Sale4.507,61934,286287,973Jun 17 04:32 PM